Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Using the Bat 24 Regimen Versus Daily and Pericoital Dosing.

Trial Profile

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Using the Bat 24 Regimen Versus Daily and Pericoital Dosing.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Dec 2013

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors CONRAD
  • Most Recent Events

    • 18 Dec 2013 Actual Planned End Date changed to 1 May 2013.
    • 18 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top